Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Q4 2021 Lantern Pharma Inc. Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Release Date Price: $6.55 (+1.24%)
Nicole Leber
Lantern Pharma Inc. - Finance & Administrative Coordinator

Good afternoon, everybody, and welcome to the Lantern Pharma Fourth Quarter and Fiscal Year 2021 Earnings Call. (Operator Instructions) I am Nicole Leber with Investor Relations at Lantern Pharma, and I will be your host for today's call. I will be joined by CEO and President, Panna Sharma; CFO, David Margrave; and CSO, Kishor Bhatia.

We issued a press release after the market closed today summarizing our financial results and progress across the company for the fourth quarter and fiscal year 2021 and a copy of this release is available through our website at lanternpharma.com and where you can also find a link to the slides that management will be referencing for today. Following the safe harbor statement, Panna will provide an overview of Lantern Pharma's operational highlights, after which David will discuss our financial results, which will be followed by Dr. Bhatia, who will provide an update on our development programs. Finally, Panna will offer some concluding comments and then we'll open the call to the Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot